Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
BLCO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

9.88

Margin Of Safety %

10

Put/Call OI Ratio

0.07

EPS Next Q Diff

0.14

EPS Last/This Y

EPS This/Next Y

0.27

Price

16.09

Target Price

18

Analyst Recom

2.6

Performance Q

-2.34

Upside

N/A

Beta

0.59

Ticker: BLCO




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-20BLCO16.750.080.003211
2026-04-23BLCO15.790.060.134413
2026-04-24BLCO15.80.062.754421
2026-04-27BLCO15.860.080.004510
2026-04-28BLCO15.720.070.004609
2026-04-29BLCO15.370.070.004652
2026-04-30BLCO15.90.070.194718
2026-05-01BLCO16.30.070.104760
2026-05-04BLCO16.310.070.004770
2026-05-05BLCO15.990.070.014829
2026-05-06BLCO15.980.070.004858
2026-05-07BLCO15.940.070.004859
2026-05-08BLCO16.180.070.004857
2026-05-11BLCO16.030.070.014954
2026-05-12BLCO16.030.070.005184
2026-05-13BLCO16.250.060.025810
2026-05-14BLCO16.260.060.475964
2026-05-15BLCO16.090.070.026213
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-16BLCO16.59172.6- 0.78
2026-04-17BLCO16.80172.6- 0.78
2026-04-20BLCO16.77172.6- 0.78
2026-04-21BLCO16.01172.6- 0.78
2026-04-22BLCO16.03172.6- 0.78
2026-04-23BLCO15.76172.6- 0.78
2026-04-24BLCO15.83172.6- 0.78
2026-04-27BLCO15.85172.6- 0.78
2026-04-28BLCO15.74176.6- 0.78
2026-04-30BLCO15.91121.9- 0.78
2026-05-01BLCO16.32121.9- 0.78
2026-05-04BLCO16.31121.9- 0.78
2026-05-05BLCO15.99125.0- 0.79
2026-05-06BLCO15.98125.0- 0.79
2026-05-07BLCO15.94128.0- 0.79
2026-05-08BLCO16.19128.0- 0.80
2026-05-11BLCO16.07128.0- 0.80
2026-05-12BLCO16.03128.0- 0.80
2026-05-13BLCO16.24128.0- 0.80
2026-05-14BLCO16.27128.0- 0.80
2026-05-15BLCO16.09128.0- 0.80
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




12 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-16BLCO0.02-0.839.52
2026-04-17BLCO0.02-0.839.52
2026-04-20BLCO0.02-0.839.52
2026-04-21BLCO0.02-0.839.52
2026-04-22BLCO0.02-0.839.52
2026-04-23BLCO0.02-0.839.52
2026-04-24BLCO0.02-0.839.62
2026-04-27BLCO0.02-0.849.88
2026-04-28BLCO0.02-0.849.88
2026-04-29BLCO0.02-0.849.88
2026-04-30BLCO0.02-0.849.88
2026-05-01BLCO0.02-0.849.88
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
12 items Current Page1 of 1

Last Quarter Act. EPS

0.08

Avg. EPS Est. Current Quarter

0.16

Avg. EPS Est. Next Quarter

0.22

Insider Transactions

0.02

Institutional Transactions

-0.84

Beta

0.59

Average Sales Estimate Current Quarter

1367

Average Sales Estimate Next Quarter

1363

Fair Value

17.66

Quality Score

55

Growth Score

78

Sentiment Score

69

Actual DrawDown %

26.7

Max Drawdown 5-Year %

Target Price

18

P/E

Forward P/E

15.26

PEG

0.39

P/S

1.12

P/B

0.91

P/Free Cash Flow

6761.76

EPS

-0.62

Average EPS Est. Cur. Y​

0.8

EPS Next Y. (Est.)

1.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-4.21

Relative Volume

1.59

Return on Equity vs Sector %

-30.4

Return on Equity vs Industry %

-13

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Bausch + Lomb Corporation
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 13000
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
BLCO

Latest News

Caricamento notizie per BLCO
stock quote shares BLCO – Bausch + Lomb Corporation Stock Price stock today
news today BLCO – Bausch + Lomb Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BLCO – Bausch + Lomb Corporation yahoo finance google finance
stock history BLCO – Bausch + Lomb Corporation invest stock market
stock prices BLCO premarket after hours
ticker BLCO fair value insiders trading